FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097199391> ?p ?o ?g. }

• W2097199391 endingPage "2947" @default.
• W2097199391 startingPage "2941" @default.
• W2097199391 abstract "What is the potential physiopathological role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in recurrent miscarriage (RM), characterized by at least three consecutive pregnancy losses. The levels of serum TRAIL immediately after miscarriage in RM patients are significantly elevated with respect to that in first-trimester normal pregnant women, and recombinant TRAIL inhibits the adhesion and migration of HTR8 trophoblastic cells in vitro. Both TRAIL and its trans-membrane receptors (TRAIL-R1, TRAIL-R2, TRAIL-R3 and TRAIL-R4) have been documented in the placenta, but their physiopathological role is incompletely understood. The study populations consisted of RM patients (n = 80) and first-trimester normal pregnant women (n = 80). Blood samples were obtained within 24 h after abortion (RM) or at gestational 12-week (normal pregnant women). As additional controls, third-trimester normal pregnant women (n = 28) were examined before (within 72 h) and after (within 24 h) partum. The concentrations of TRAIL were analysed in serum samples by ELISA. In parallel, the effect of soluble recombinant TRAIL (0.1–1000 ng/ml) was analysed on the survival of primary extravillus trophoblasts (EVTs) and on the survival, proliferation, adhesion and migration of trophoblastic HTR8 cells. The circulating levels of TRAIL in RM women (median: 52.5 pg/ml; mean and SD: 55.5 ± 24.4 pg/ml) were significantly higher with respect to first-trimester normal pregnant women (median: 44.9 pg/ml; mean and SD: 47 ± 15.1 pg/ml) and third-trimester normal pregnant women, as assessed before (median: 45.1 pg/ml; mean and SD: 46 ± 12.4 pg/ml) and after partum (median: 35.4 pg/ml; mean and SD: 38 + 17.5 pg/ml). Both primary EVT and HTR8 cells expressed detectable levels of TRAIL death receptors, but exposure to soluble recombinant TRAIL did not induce cell death of trophoblastic cells. On the other hand, TRAIL dose-dependently inhibited the adhesion of HTR8 cells to decidual endothelial cells (DEC) as well as the migration of HTR8 in transwell assays using either fibronectin or DEC. Although this study suggests that TRAIL might have a pathogenic role in RM by inhibiting both the adhesion and migration capabilities of first trimester trophoblastic cells, there is a possibility that the elevated serum levels of TRAIL in RM are not cause but rather the result of RM. Our current findings together with data of other authors suggest that circulating TRAIL should be further analysed as a potential important biomarker in different physiopathological settings. This study was funded by FIRB projects (RBAP11Z4Z9_002 to Giorgio Zauli and RBAP10447J_002 to Paola Secchiero). The authors have no competing interests to declare." @default.
• W2097199391 created "2016-06-24" @default.
• W2097199391 creator A5011847088 @default.
• W2097199391 creator A5038571648 @default.
• W2097199391 creator A5043662372 @default.
• W2097199391 creator A5075079041 @default.
• W2097199391 creator A5082312639 @default.
• W2097199391 creator A5086826541 @default.
• W2097199391 creator A5091180110 @default.
• W2097199391 date "2012-08-21" @default.
• W2097199391 modified "2023-10-17" @default.
• W2097199391 title "Soluble TRAIL is elevated in recurrent miscarriage and inhibits the in vitro adhesion and migration of HTR8 trophoblastic cells" @default.
• W2097199391 cites W1977588471 @default.
• W2097199391 cites W1979396507 @default.
• W2097199391 cites W1989745299 @default.
• W2097199391 cites W2002914972 @default.
• W2097199391 cites W2007844203 @default.
• W2097199391 cites W2011250979 @default.
• W2097199391 cites W2020049891 @default.
• W2097199391 cites W2039491348 @default.
• W2097199391 cites W2042942160 @default.
• W2097199391 cites W2044300363 @default.
• W2097199391 cites W2050273259 @default.
• W2097199391 cites W2057691191 @default.
• W2097199391 cites W2061735639 @default.
• W2097199391 cites W2077537421 @default.
• W2097199391 cites W2078987846 @default.
• W2097199391 cites W2092228026 @default.
• W2097199391 cites W2104608023 @default.
• W2097199391 cites W2113400357 @default.
• W2097199391 cites W2115547580 @default.
• W2097199391 cites W2123003587 @default.
• W2097199391 cites W2127114138 @default.
• W2097199391 cites W2138167778 @default.
• W2097199391 cites W2151162913 @default.
• W2097199391 cites W2152337424 @default.
• W2097199391 cites W2154585821 @default.
• W2097199391 cites W2171825270 @default.
• W2097199391 doi "https://doi.org/10.1093/humrep/des289" @default.
• W2097199391 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22914768" @default.
• W2097199391 hasPublicationYear "2012" @default.
• W2097199391 type Work @default.
• W2097199391 sameAs 2097199391 @default.
• W2097199391 citedByCount "26" @default.
• W2097199391 countsByYear W20971993912013 @default.
• W2097199391 countsByYear W20971993912014 @default.
• W2097199391 countsByYear W20971993912015 @default.
• W2097199391 countsByYear W20971993912016 @default.
• W2097199391 countsByYear W20971993912018 @default.
• W2097199391 countsByYear W20971993912019 @default.
• W2097199391 countsByYear W20971993912020 @default.
• W2097199391 countsByYear W20971993912021 @default.
• W2097199391 countsByYear W20971993912022 @default.
• W2097199391 countsByYear W20971993912023 @default.
• W2097199391 crossrefType "journal-article" @default.
• W2097199391 hasAuthorship W2097199391A5011847088 @default.
• W2097199391 hasAuthorship W2097199391A5038571648 @default.
• W2097199391 hasAuthorship W2097199391A5043662372 @default.
• W2097199391 hasAuthorship W2097199391A5075079041 @default.
• W2097199391 hasAuthorship W2097199391A5082312639 @default.
• W2097199391 hasAuthorship W2097199391A5086826541 @default.
• W2097199391 hasAuthorship W2097199391A5091180110 @default.
• W2097199391 hasBestOaLocation W20971993911 @default.
• W2097199391 hasConcept C131872663 @default.
• W2097199391 hasConcept C16685009 @default.
• W2097199391 hasConcept C172680121 @default.
• W2097199391 hasConcept C2776953305 @default.
• W2097199391 hasConcept C2778376644 @default.
• W2097199391 hasConcept C2778642596 @default.
• W2097199391 hasConcept C2779234561 @default.
• W2097199391 hasConcept C2779245376 @default.
• W2097199391 hasConcept C2780625311 @default.
• W2097199391 hasConcept C29456083 @default.
• W2097199391 hasConcept C46973012 @default.
• W2097199391 hasConcept C54355233 @default.
• W2097199391 hasConcept C71924100 @default.
• W2097199391 hasConcept C86803240 @default.
• W2097199391 hasConceptScore W2097199391C131872663 @default.
• W2097199391 hasConceptScore W2097199391C16685009 @default.
• W2097199391 hasConceptScore W2097199391C172680121 @default.
• W2097199391 hasConceptScore W2097199391C2776953305 @default.
• W2097199391 hasConceptScore W2097199391C2778376644 @default.
• W2097199391 hasConceptScore W2097199391C2778642596 @default.
• W2097199391 hasConceptScore W2097199391C2779234561 @default.
• W2097199391 hasConceptScore W2097199391C2779245376 @default.
• W2097199391 hasConceptScore W2097199391C2780625311 @default.
• W2097199391 hasConceptScore W2097199391C29456083 @default.
• W2097199391 hasConceptScore W2097199391C46973012 @default.
• W2097199391 hasConceptScore W2097199391C54355233 @default.
• W2097199391 hasConceptScore W2097199391C71924100 @default.
• W2097199391 hasConceptScore W2097199391C86803240 @default.
• W2097199391 hasIssue "10" @default.
• W2097199391 hasLocation W20971993911 @default.
• W2097199391 hasLocation W20971993912 @default.
• W2097199391 hasLocation W20971993913 @default.
• W2097199391 hasOpenAccess W2097199391 @default.
• W2097199391 hasPrimaryLocation W20971993911 @default.
• W2097199391 hasRelatedWork W2069772639 @default.

• next